Product correctly added to cart.

discount label
4-Hydroxycinnamamide
View 3D

Biosynth logo

4-Hydroxycinnamamide

CAS: 194940-15-3

Ref. 3D-UHA94015

250mg
229.00 €
2500mg
894.00 €
Estimated delivery in United States, on Wednesday 15 Jan 2025

Product Information

Name:
4-Hydroxycinnamamide
Description:

4-Hydroxycinnamamide is a natural compound that has been shown to inhibit the enzyme activities of lysine and hydroxylysine residues. It also inhibits the growth of chronic lymphocytic leukemia cells in vitro, with an IC50 of 0.2 μM. 4-Hydroxycinnamamide may be used as an anti-cancer drug for the treatment of various cancers, including skin cancer and melanoma. This compound also has antioxidant properties, which make it a potential candidate for use in treating infectious diseases such as malaria and HIV/AIDS.br>br>
The mechanism behind 4-hydroxycinnamamide's anticancer effects is not well understood, but it appears to promote cellular uptake and prevent cell death by apoptosis. In addition, this compound may inhibit the activity of histone lysine methyltransferases and therefore regulate DNA methylation patterns.br>br>
4-Hydroxycinnamamide is thought to have a

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
163.17 g/mol
Formula:
C9H9NO2
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-UHA94015 4-Hydroxycinnamamide

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".